Probstfield J L, Russell M L, Henske J C, Reardon R J, Insull W
Am J Med. 1986 May;80(5):777-84. doi: 10.1016/0002-9343(86)90615-7.
This is a report of a successful program to return dropout participants to active participation at a single clinic of a multicenter long-term clinical trial, the Coronary Primary Prevention Trial of the Lipid Research Clinics Program. The specific objectives were to re-engage dropouts into active participation and to have them resume study medication. Thirty-six men had been absent from the Baylor-Methodist Clinic for 10 months to over four years. The program focused on resolving the presenting problems: psychosocial, somatic, and drug adherence. It was based on six general principles with corresponding goals and employed 13 activities and procedures in a specific operational sequence for reinstitution of the Coronary Primary Prevention Trial protocol. Counseling techniques were used to improve protocol adherence. The recovery program was monitored bi-weekly by computer. The dropout group did not appear to exhibit any biases and approximated the remainder of the Baylor-Methodist cohort demographically. At six months into the recovery program, 90 percent of the dropouts had been recovered. Seventy percent of the recovered participants re-established medication-taking behavior. The mean rate of adherence to medication for all of the recovered group was 35 percent of the prescribed dose, 8 g per day. Review of the data for the cholesterol differential between the two treatment groups demonstrated a favorable effect of the reinstitution of the study medication. The program's methods are applicable to clinical practice.
这是一份关于一项成功项目的报告,该项目旨在使多中心长期临床试验——脂质研究临床项目冠状动脉一级预防试验中一家诊所的失访参与者重新积极参与试验。具体目标是让失访者重新积极参与,并恢复服用研究药物。36名男性已从贝勒-卫理公会诊所失访10个月至四年多。该项目着重解决现存问题:心理社会问题、躯体问题和药物依从性问题。它基于六项一般原则及相应目标,并按照特定操作顺序采用了13项活动和程序,以重新实施冠状动脉一级预防试验方案。运用咨询技巧来提高方案依从性。通过计算机对康复项目进行每两周一次的监测。失访组似乎未表现出任何偏差,在人口统计学上与贝勒-卫理公会队列的其余部分相近。在康复项目进行到六个月时,90%的失访者已恢复参与。70%恢复参与的参与者重新建立了服药行为。所有恢复参与组的药物平均依从率为规定剂量(每天8克)的35%。对两个治疗组之间胆固醇差异数据的审查表明,重新服用研究药物产生了有利效果。该项目的方法适用于临床实践。